USP24 promotes drug resistance during cancer therapy
نویسندگان
چکیده
منابع مشابه
Phthalate exposure promotes chemotherapeutic drug resistance in colon cancer cells
Phthalates are widely used as plasticizers. Humans can be exposed to phthalates through ingestion, inhalation, or treatments that release di(2-ethylhexyl) phthalate (DEHP) and its metabolite, mono(2-ehylhexyl) phthalate (MEHP), into the body from polyvinyl chloride-based medical devices. Phthalate exposure may induce reproductive toxicity, liver damage, and carcinogenesis in humans. This study ...
متن کاملSmad4 inactivation promotes malignancy and drug resistance of colon cancer.
SMAD4 is localized to chromosome 18q21, a frequent site for loss of heterozygosity in advanced stage colon cancers. Although Smad4 is regarded as a signaling mediator of the TGFβ signaling pathway, its role as a major suppressor of colorectal cancer progression and the molecular events underlying this phenomenon remain elusive. Here, we describe the establishment and use of colon cancer cell li...
متن کاملGlucose-dependent acetylation of Rictor promotes targeted cancer therapy resistance.
Cancer cells adapt their signaling in response to nutrient availability. To uncover the mechanisms regulating this process and its functional consequences, we interrogated cell lines, mouse tumor models, and clinical samples of glioblastoma (GBM), the highly lethal brain cancer. We discovered that glucose or acetate is required for epidermal growth factor receptor vIII (EGFRvIII), the most comm...
متن کاملA delay-dependent model with HIV drug resistance during therapy
Article history: Received 25 April 2013 Available online 7 January 2014 Submitted by J. Shi
متن کاملChanging patterns of plasmid-mediated drug resistance during tetracycline therapy.
The patterns of drug resistance and the frequency of conjugative R plasmids in intestinal Escherichia coli from 88 patients treated for a skin disease (acne vulgaris) with low oral doses of tetracycline are reported. The proportion of patients with resistant bacteria was progressively greater in patients who received tetracycline for 1 week, 4 weeks, or longer (from 50 to 88%). No multiply drug...
متن کاملذخیره در منابع من
با ذخیره ی این منبع در منابع من، دسترسی به آن را برای استفاده های بعدی آسان تر کنید
ژورنال
عنوان ژورنال: Cell Death & Differentiation
سال: 2021
ISSN: 1350-9047,1476-5403
DOI: 10.1038/s41418-021-00778-z